Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,401 |
Reported balance
After 2022-04-01 transaction · row 1
1 source rowRow 1 · 2022-04-01 · Tax withholding · Disposed 384 · Balance 47,401 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $60.75 | $7,958.25 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,270 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 00:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-007679 · marketforms-49586.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,270 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2020, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:40 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,126 | $67.28 | $75,757.28 |
DisclosureSEC source: 0001214659-20-007444 · marketforms-49487.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,480 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:44 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 20,000 | $37.25 | $744,940.00 |
DisclosureSEC source: 0001214659-20-005528 · marketforms-49015.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,606 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $37.11 to $37.57 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,126 | $39.76 | $44,769.76 |
DisclosureSEC source: 0001214659-20-004965 · marketforms-48849.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,606 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 23:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 824 | $33.13 | $27,299.12 |
DisclosureSEC source: 0001214659-20-001754 · marketforms-47855.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,213 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,742 | $28.66 | $49,923.98 |
DisclosureSEC source: 0001214659-20-001630 · marketforms-47797.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,037 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.22 to $29.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 598 | $30.72 | $18,371.76 |
DisclosureSEC source: 0001214659-20-001630 · marketforms-47797.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,779 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.44 to $31.23 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,492 | $30.69 | $107,165.99 |
DisclosureSEC source: 0001214659-20-001630 · marketforms-47797.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,377 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.36 to $31.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionStock Option (right to buy) · Derivative | 1,599 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,752 Underlying: Common Stock · 1,599 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · derivative.exercise_date: The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019, and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionStock Option (right to buy) · Derivative | 6,081 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,351 Underlying: Common Stock · 6,081 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · derivative.exercise_date: The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019, and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,599 | $28.16 | $45,024.64 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,869 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.00 to $28.29 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,599 | $26.66 | $42,629.34 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,081 | $28.16 | $171,228.80 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,869 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.00 to $28.29 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 01:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 6,081 | $26.66 | $162,119.46 |
DisclosureSEC source: 0001214659-20-001163 · marketforms-47704.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,462 | $26.58 | $38,859.96 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,869 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.45 to $26.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,029 | $25.90 | $52,540.96 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,331 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.44 to $26.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 172 | $26.60 | $4,574.34 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,360 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.51 to $26.67 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 426 | $25.96 | $11,059.81 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,532 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.50 to $26.49 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,491 | $26.21 | $91,499.11 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,958 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.89 to $26.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 599 | $26.20 | $15,693.80 |
DisclosureSEC source: 0001214659-20-001010 · marketforms-47679.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,449 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.91 to $26.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,023 | $23.06 | $23,585.27 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,048 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.87 to $23.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,468 | $22.22 | $54,829.09 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,071 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.83 to $22.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 163 | $23.06 | $3,758.78 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,539 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.91 to $23.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 435 | $22.23 | $9,668.75 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,702 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.85 to $22.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,491 | $22.30 | $77,842.32 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,137 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.04 to $22.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 598 | $22.24 | $13,298.32 |
DisclosureSEC source: 0001214659-20-000556 · marketforms-47526.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,628 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.03 to $22.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 08, 2020 Filed Jan 11, 2020 01:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,491 | $21.50 | $75,046.03 |
DisclosureSEC source: 0001214659-20-000293 · marketforms-47404.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,226 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.22 to $21.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 08, 2020 Filed Jan 11, 2020 01:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 599 | $21.52 | $12,891.08 |
DisclosureSEC source: 0001214659-20-000293 · marketforms-47404.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,717 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.22 to $21.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,682 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · derivative · entry 15 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,920 Underlying: Common Stock · 3,682 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F9 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,682 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · derivative · entry 14 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935 Underlying: Common Stock · 3,682 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,798 | $24.34 | $43,759.72 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 11 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,287 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,884 | $23.59 | $44,449.21 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 10 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,085 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $24.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,810 | $24.34 | $44,055.40 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 9 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,969 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,872 | $23.58 | $44,138.02 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,779 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $23.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,682 | $8.82 | $32,475.24 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,682 | $5.95 | $21,907.90 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,662 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · derivative · entry 13 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,602 Underlying: Common Stock · 3,662 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F9 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,702 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · derivative · entry 12 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,617 Underlying: Common Stock · 3,702 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,662 | $23.34 | $85,478.40 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,287 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.81 to $23.70 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,662 | $23.34 | $85,452.77 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,949 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.81 to $23.70 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 40 | $22.82 | $912.80 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,611 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,662 | $8.82 | $32,298.84 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,702 | $5.95 | $22,026.90 |
DisclosureSEC source: 0001209191-19-053541 · doc4.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,455 | $0.00 Strike: $882.00 | $0.00 |
DisclosureSEC source: 0001209191-19-052210 · doc4.xml · derivative · entry 22 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,264 Underlying: Common Stock · 2,455 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,910 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-19-052210 · doc4.xml · derivative · entry 21 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,319 Underlying: Common Stock · 4,910 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,430 | $22.92 | $32,775.60 |
DisclosureSEC source: 0001209191-19-052210 · doc4.xml · nonDerivative · entry 18 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,287 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F15 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.65 to $23.40 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,025 | $22.11 | $22,661.73 |
DisclosureSEC source: 0001209191-19-052210 · doc4.xml · nonDerivative · entry 17 Weiss Patrick · CIK 0001755793 · SVP, R&D GM Data Storage 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,717 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F14 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.60 to $22.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.